The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

GlobalInfoResearch Reports

SynopsisThe global Bevacizumab Monoclonal Antibody Biosimilar market size was valued at USD 1379.8 million in 2022 and is forecast to a readjusted size of USD 484.9 million by 2029 with a CAGR of -13.9% during review period. The influence of COVID-19 and the Russia-Uk.....

No Of Pages : 72
Publication Date: Mar, 2025
Single User Price : US$ 3,480.00